Showing results (141-150 of 1,286) with videos related to

Sort By:
Pageof 129
The Journal of Urology|April 1, 1989
The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasiaJ P Weber, J E Oesterling, C A Peters, et al.
Urology|December 1, 1996
Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and ageA W Partin, W J Catalona, P C Southwick, et al.
The Journal of Urology|November 1, 1989
A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysisA W Partin, A C Walsh, R V Pitcock, et al.
The Journal of Urology|September 1, 1996
Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasiaL S Marks, F J Dorey, T Rhodes, et al.
Cancer|July 1, 1992
Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancerA W Partin, G D Steinberg, R V Pitcock, et al.
Cancer Research|February 15, 1993
Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancerA W Partin, R H Getzenberg, M J CarMichael, et al.
Cancer|April 8, 1999
Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patientsT J Polascik, M J Manyak, M K Haseman, et al.
Journal of the National Cancer Institute|November 6, 2003
Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsiesSusan V Harden, Harriette Sanderson, Steven N Goodman, et al.
Urology|May 1, 1995
Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasiaJ A Cadeddu, J D Pearson, B R Lee, et al.
The Journal of Urology|July 1, 1993
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancerA W Partin, J Yoo, H B Carter, et al.
Pageof 129